Hodgkin's lymphoma and acute lymphoblastic leukemia—two types of cancer that affect blood cells—do not respond adequately to treatment with CAR-T cells. The therapy involves harvesting the patient's ...

A pair of recent studies from the laboratory of Bin Zhang, MD, Ph.D., the Johanna Dobe Professor of Cancer Immunology, have ...

The researchers said the approach potentially could work for a variety of types of tumors. An estimated 26,890 people in the U.S. were diagnosed with stomach cancer, and 10,880 died of the disease ...

SSRIs boosted the ability of T cells to kill cancer cells and suppressed tumor growth in both mouse and human tumor models.

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

Former US President Joe Biden diagnosed with prostate cancer, a common cancer in men, with various treatment options ...

A team led by researchers at Baylor College of Medicine has identified flavonoids, natural compounds found in plants, that are toxic to bladder cancer cells cultured in the lab. The researchers report ...

it can also reduce the attraction of immunosuppressive cells (such as : TAM, Treg, and MDSCs) into the TME, so as to achieve the remodeling of the TME, which is more conducive to obtaining the ...

The cause of prostate cancer is unknown, but it occurs when cells in the prostate start ... targeted therapy and immunotherapy, according to the Mayo Clinic. Treatment options depend largely ...

Key highlights include: IMAN immunotherapy demonstrates superior tumour penetration and direct cancer cell killing: IMANs, whether haematopoietic stem cell- or induced pluripotent stem cell-derived, ...